Human Myeloperoxidase from Neutrophils Native

<strong>Human Myeloperoxidase from Neutrophils Native</strong>_x000D_ <strong>Catalog number:</strong> B2017022_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Myeloperoxidas_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Dufour D, Khalil A, Nuyens V, Rousseau A, Delporte C, Noyon C, Cortese M, Reyé F, Pireaux V, Nève J, Vanhamme L, Robaye B, Lelubre C, Desmet JM, Raes M, Boudjeltia KZ, Van Antwerpen P. Native and myeloperoxidase-oxidized low-density lipoproteins act in synergy to induce release of resolvin-D1 from endothelial cells Atherosclerosis. 2018 May;272:108-117._x000D_ 2: Ohinata H, Obama T, Makiyama T, Watanabe Y, Itabe H. High-Density Lipoprotein Suppresses Neutrophil Extracellular Traps Enhanced by Oxidized Low-Density Lipoprotein or Oxidized Phospholipids Int J Mol Sci. 2022 Nov 13;23(22):13992._x000D_ 3: Frangie C, Daher J. Role of myeloperoxidase in inflammation and atherosclerosis (Review) Biomed Rep. 2022 Jun;16(6):53._x000D_ 4: Cao Z, Cheng G. Recombinant Myeloperoxidase as a New Class of Antimicrobial Agents Microbiol Spectr. 2022 Feb 23;10(1):e0052221._x000D_ 5: Audrain MA, Baranger TA, Moguilevski N, Martin SJ, Devys A, Lockwood CM, Muller JY, Esnault VL. Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies Clin Exp Immunol. 1997 Jan;107(1):127-34._x000D_ 6: Chistiakov DA, Orekhov AN, Bobryshev YV. ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease Lab Invest. 2016 Jul;96(7):708-18._x000D_ 7: Esposito I, Kontra I, Giacomassi C, Manou-Stathopoulou S, Brown J, Stratton R, Verykokou G, Buccafusca R, Stevens M, Nissim A, Lewis MJ, Pfeffer PE. Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma Front Immunol. 2023 Jun 2;14:1164941._x000D_ 8: Grigorieva DV, Gorudko IV, Grudinina NA, Panasenko OM, Semak IV, Sokolov AV, Timoshenko AV. Lactoferrin modified by hypohalous acids: Partial loss in activation of human neutrophils Int J Biol Macromol. 2022 Jan 15;195:30-40._x000D_ 9: Pember SO, Shapira R, Kinkade JM Jr. Multiple forms of myeloperoxidase from human neutrophilic granulocytes: evidence for differences in compartmentalization, enzymatic activity, and subunit structure Arch Biochem Biophys. 1983 Mar;221(2):391-403._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/31864385">10: Nonokawa M, Suzuki K, Hayashi H, Nishibata Y, Masuda S, Nakazawa D, Tanaka S, Tomaru U, Ishizu A. Native myeloperoxidase is required to make the experimental vasculitis model Arthritis Res Ther. 2019 Dec 21;21(1):296. </a>_x000D_ _x000D_ <strong>Products Related to Human Myeloperoxidase from Neutrophils Native can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>